'Clue' to cystic fibrosis infection
- 21 August 2015
- From the section Health
American scientists have shed light on why a common and often serious lung infection in people who have cystic fibrosis can be so hard to treat.
Researchers at the University of Washington have discovered different survival traits in bacteria, depending on where in the lungs they are lodged.
Scientists say this may have helped some bugs evade antibiotic therapy.
One in every 2,500 babies born in the UK has the genetic condition which affects the lungs and digestive system.
The mucus produced leaves people prone to stubborn lung infections, often caused by Pseudomonas aeruginosa bacteria.
Inspecting lung specimens, researchers discovered that separate regions of the same lung had vast arrays of pseudomonas that behaved differently, despite originating from the same strain of bug.
Dramatically different resistance
Scientists hypothesise that over time the bacteria become geographically separated (for example by mucus) and then evolve different characteristics to help them survive in these new conditions.
And according to lead researcher, Dr Peter Jorth, some of the bacteria they studied developed "dramatically" different levels of resistance to antibiotics.
Researcher Dr Pradeep Singh added: "This may be part of what makes treatment so difficult. When bacteria sensitive to one kind of stress - for example an antibiotic - are killed, functionally different sibling bacteria are there to take their place.
"This diversity provides insurance for the bacteria in a way because others can take their place if the antibiotics work on them."
Researchers say this also raises the possibility that other chronic infections - such as wound and sinus infections - have similar mixtures of bacteria.
But they caution more work needs to be done to replicate these early results.
The study appears in Cell Host & Microbe.
Dr Keith Brownlee, from the Cystic Fibrosis Trust, said: "The findings of this research are interesting.
"It's great to see researchers working hard to understand how respiratory infections develop and progress."
"The greater understanding we have the more informed clinicians can be. This allows them to advise people with cystic fibrosis more effectively to help manage their condition and help prevent lung damage."